retatrutide triple agonist weight loss trial 🚨The first phase 3 trial, TRIUMPH-4, top-line data announced today 🚨 💉 Retatrutide, a GLP-1,GIP, glucagon studied in patients with obesity and osteoarthritis 📉 28.7% at 68 do glp 1 patches glp-1 support Subscription:3-months

retatrutide triple agonist weight loss trial 🚨The first phase 3 trial, TRIUMPH-4, top-line data announced today 🚨 💉 Retatrutide, a GLP-1,GIP, glucagon studied in patients with obesity and osteoarthritis 📉 28.7% at 68 do glp 1 patches glp-1 support Subscription:3-months

do glp 1 patches cause diarrhea on a GLP-1 is common, predictable, and manageable. Here's what's driving it and what to about it. #obesitymedicine #womenshealth #obesitydoctor​​​​​​​​​​​​​​​​ Does GLP-1 Make You Poop? –

At eight years, the cumulative incidence of the primary endpoint was 21.7% (95% CI, 12.2-30.6) in the surgical group and 45.1% (95% CI, 27.7-58.4) in the nonsurgical group (adjusted HR [aHR], 0.40

glp-1 support

Subscription:3-months

Full Bio | LinkedIn Last reviewed: July 24, 2026 Quick answer: GLP-1 microdosing is not a standardized FDA-approved treatment regimen